Clinical Trial Update: A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CDX-1401 vaccine with or without CDX-301 for various-stage melanoma has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma

Drugs mentioned

• CDX-1401
• CDX-301

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cutaneous Melanoma, Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2021-11-16